This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Anacor Pharmaceuticals Inc (ANAC)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 15.99M 114.76M 10.34M 15.17M
Receivables 5.71M 1.32M 1.20M 1.14M
Inventories 2.52M 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 160.57M 155.41M 49.29M 53.04M
Property, Plant & Equipment, Gross 7.40M 6.72M 6.27M 5.83M
Accumulated Depreciation & Depletion 5.76M 5.26M 4.76M 4.09M
Property, Plant & Equipment, Net 1.64M 1.46M 1.52M 1.74M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 45.90M 15.29M 262.00K 1.00M
Total Non-Current Assets 48.48M 16.75M 1.78M 2.74M
Liabilities & Shareholder Equity
Total Assets 209.05M 172.16M 51.07M 55.79M
Accounts Payable 4.52M 4.71M 3.02M 3.02M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 1.47M 1.98M 0.00 0.00
Total Current Liabilities 28.65M 16.23M 25.39M 21.02M
Long Term Debt 59.97M 28.02M 15.84M 13.71M
Deferred Income Taxes 901.00K 1.22M 836.00K 925.00K
Other Non-Current Liabilities 40.69M 5.27M 4.19M 6.23M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 101.56M 34.50M 20.87M 20.86M
Total Liabilities 130.22M 50.73M 46.26M 41.89M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 78.83M 121.43M 4.81M 13.90M
Common Par 42.00K 41.00K 36.00K 28.00K
Additional Paid In Capital 296.53M 251.84M 219.98M 173.00M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -217.59M -130.45M -215.21M -159.12M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -145.00K -2.00K 3.00K 0.00
Total Capitalization 138.80M 149.45M 20.65M 27.60M
Total Equity 78.83M 121.43M 4.81M 13.90M
Total Liabilities & Stock Equity 209.05M 172.16M 51.07M 55.79M
Total Common Shares Outstanding 43.27M 41.54M 35.59M 28.19M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 42.24M 39.18M 31.90M 28.11M
Diluted Weighted Shares Outstanding 42.24M 40.32M 31.90M 28.11M
Number of Employees 100 79 85 80
Number of Part-Time Employees 0 0 0 0

ANAC Anacor Pharmaceuticals Inc

Chart of ANAC

Analysts Ratings for ANAC

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 4
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

ANAC Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs